It is important to acknowledge that, in addition to KIAA0101, our results also showed that miR-183 had the ability to target the 3′-UTRs and inhibit transcript expression of PLK1, CCNB1, SPC25, and PSEN2 (
Supplementary Table S2,
Supplementary Fig. S1). These genes can also potentially contribute to functional effects of miR-183 on cell cycle and DNA repair. PLK1 has multiple important roles in cell cycle progression and in cellular response to DNA damage
40–43; it strongly promotes progression of the cell cycle and is responsible for aggressive proliferation of tumor cells
44; and its over-expression enables cells to override checkpoints, leading to genomic instability and promoting cell transformation.
45 Similarly, CCNB1 is one of the principal mitotic cyclins in animals.
46 Although knockdown of CCNB1 by siRNA only delays temporarily chromatin condensation, nuclear CCNB1 cooperates with cyclin A2 to the early mitotic events and appears to be particularly critical for the maintenance of the mitotic state.
47 CCNB1 expression is frequently elevated in human cancers and is associated with tumor aggressiveness and poor clinical outcome.
48 SPC25 is a component of the NDC80 kinetochore complex required, along with SPC24, to establish and maintain kinetochore-microtubule attachment.
49,50 Finally, PSEN2 is one of the enzymatic components of the γ-secretase complex that cleaves amyloid precursor protein, as well as other proteins.
51 Inhibition of PSEN2 appears to have different effects on cancer cells. While siRNA-mediated inhibition of presenilin 2 inhibits glioma cell growth and invasion,
52 similar inhibition by siRNA has been demonstrated to increased lung cancer cell growth.
53 Therefore, the inhibition of PSEN2 by miR-183 could also contribute to the differences in the effects of this microRNA on the growth of different types of cancer cells.